While CB1 and CB2 are obviously involved in anti-tumorigenic mechanisms, it is uncertain whether the expression levels of the two receptors can serve as prognostic markers and allow a conclusion on the malignancy degree of the cancer. Here, CNR1 is linked to cancer.